<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38194938</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Respiration; international review of thoracic diseases</Title><ISOAbbreviation>Respiration</ISOAbbreviation></Journal><ArticleTitle>COVID-19 after 2 Years from Hospital Discharge: A Pulmonary Function and Chest Computed Tomography Follow-Up Study.</ArticleTitle><Pagination><StartPage>22</StartPage><EndPage>31</EndPage><MedlinePgn>22-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000535732</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Serial follow-up with pulmonary function testing (PFT) and chest computed tomography (CT) after severe COVID-19 are recommended. As a result, many longitudinal studies have been published on COVID-19 of different grade of severity up to 1-year follow-up. Therefore, we aimed at a long-term observational study throughout 2 years after severe COVID-19.</AbstractText><AbstractText Label="METHODS">Severe COVID-19 patients were consecutively recruited after hospital discharge between March and June 2020 and prospectively followed up for 24 months, with mMRC dyspnea scale and PFT at 6, 12, and 24 months. Chest CT was performed when clinically indicated.</AbstractText><AbstractText Label="RESULTS">One hundred one patients enrolled completed the observational study. At 24 months, those with reduced total lung capacity (TLC) were 16%, associated with fibrotic ground glass opacity (GGO) and mMRC score &amp;gt;1, respectively, in 75% and 69% of them. At 24 months, those with a reduced diffusing capacity of the lung for CO were 41%, associated with fibrotic GGO and mMRC score &amp;gt;1, respectively, in 53% and 22% of them.</AbstractText><AbstractText Label="CONCLUSION">Two years after hospitalization for severe COVID-19, a non-negligible number of patients still suffer from "long COVID" due to respiratory damage.</AbstractText><CopyrightInformation>&#xa9; 2024 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mennella</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>S.C. Radiologia P.O. Levante, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alicino</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Direzione Sanitaria, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anselmo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento Medico, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrega</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>S.C. Malattie Infettive Osteoarticolari, ASL2 Savonese, Albenga, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ficarra</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>S.C. Radiologia P.O. Levante, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garra</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Direzione Sanitaria, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gastaldo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>S.C. Radiologia P.O. Levante, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnerre</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dipartimento Medico, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lillo</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>S.C. Laboratorio di Patologia Clinica, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassara</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento Medico, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terrile</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>S.C. Laboratorio di Patologia Clinica, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milanese</LastName><ForeName>Manlio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento Medico, ASL2 Savonese, Savona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ACOD Group.</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Respiration</MedlineTA><NlmUniqueID>0137356</NlmUniqueID><ISSNLinking>0025-7931</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chest computed tomography</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Spirometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>18</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38194938</ArticleId><ArticleId IdType="doi">10.1159/000535732</ArticleId><ArticleId IdType="pii">000535732</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>